These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31982544)

  • 21. Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia.
    Wang Y; Zhou W; Alter BP; Wang T; Spellman SR; Haagenson M; Yeager M; Lee SJ; Chanock SJ; Savage SA; Gadalla SM
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2003-2008. PubMed ID: 29879518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.
    Guardiola P; Socié G; Li X; Ribaud P; Devergie A; Espérou H; Richard P; Traineau R; Janin A; Gluckman E
    Blood; 2004 Jan; 103(1):73-7. PubMed ID: 12946993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
    Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
    Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective identification of the first cord blood-transplanted severe aplastic anemia in a
    Fink FM; Höpfl R; Witsch-Baumgartner M; Kropshofer G; Martin S; Fink V; Heeg M; Peters C; Zschocke J; Haas OA
    Front Immunol; 2024; 15():1430938. PubMed ID: 39114664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.
    Virts EL; Jankowska A; Mackay C; Glaas MF; Wiek C; Kelich SL; Lottmann N; Kennedy FM; Marchal C; Lehnert E; Scharf RE; Dufour C; Lanciotti M; Farruggia P; Santoro A; Savasan S; Scheckenbach K; Schipper J; Wagenmann M; Lewis T; Leffak M; Farlow JL; Foroud TM; Honisch E; Niederacher D; Chakraborty SC; Vance GH; Pruss D; Timms KM; Lanchbury JS; Alpi AF; Hanenberg H
    Hum Mol Genet; 2015 Sep; 24(18):5093-108. PubMed ID: 26085575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical analysis of 76 patients with severe aplastic anemia treated with haploid hematopoietic stem cell transplantation].
    Zhang Y; Zhang GX; Pang AM; Yang DL; Zhang RL; Zhai WH; Wei JL; He Y; Jiang EL; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):202-210. PubMed ID: 37356981
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
    Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
    Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT.
    Zubicaray J; Pagliara D; Sevilla J; Eikema DJ; Bosman P; Ayas M; Zecca M; Yesilipek A; Kansoy S; Renard C; Dalle JH; Campos A; Faraci M; Kupesiz A; Smiers FJW; Velardi A; Abecasis M; Corti P; Fagioli F; González Muñiz S; Kriván G; Dufour C; Risitano A; Corbacioglu S; Peffault de Latour R
    Am J Hematol; 2021 May; 96(5):571-579. PubMed ID: 33606297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia.
    Alsaggaf R; Katta S; Wang T; Hicks BD; Zhu B; Spellman SR; Lee SJ; Horvath S; Gadalla SM
    Transplant Cell Ther; 2021 Apr; 27(4):313.e1-313.e8. PubMed ID: 33836872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular approaches to the treatment of Fanconi anemia: recent advances.
    Otsuki T; Liu JM
    Keio J Med; 1998 Mar; 47(1):42-4. PubMed ID: 9560531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
    Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
    Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of bone marrow transplantation in acquired and inherited aplastic anaemia in the Republic of Ireland.
    Piccin A; O'Marcaigh A; Smith O; O'Riordan J; Crowley M; Vandenberg E; Gardiner N; McCann S
    Ir J Med Sci; 2005; 174(3):13-9. PubMed ID: 16285332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
    Li Q; Luo C; Luo C; Wang J; Li B; Ding L; Chen J
    Ann Hematol; 2017 Aug; 96(8):1389-1397. PubMed ID: 28623394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations.
    Tryon R; Zierhut H; MacMillan ML; Wagner JE
    Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Mixed Chimerism After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients With Fanconi Anemia Impact on Outcome?
    Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Al-Anazi A; Khan S; El-Solh H; Al-Seraihi A
    Transplant Cell Ther; 2021 Mar; 27(3):257.e1-257.e6. PubMed ID: 33781527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of Fanconi anemia from aplastic anemia by chromosomal breakage test.
    Hou JW; Wang TR
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(2):121-6. PubMed ID: 9151465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular diagnosis and hematopoietic stem cell transplantation in 17 children with inherited bone marrow failure syndrome].
    Li Q; Li B; Luo C; Wang J; Luo C; Ding L; Chen J
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):817-23. PubMed ID: 26758319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.